▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2824 by analyst upside · 2026-11-14
MRX
Marex Group Limited
Financial Services · Market Cap $5B · P/E 13.0x
ANALYST PRICE TARGET
+17.2%
implied upside to consensus target
Current Price $70.72
Consensus Target $82.88
Bull Target $101.0
Bear Target $36.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
4
Hold
1
Sell
0
52-Week Low $31.19
52-Week High $79.11
YTD Return +88.1%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 13.0x
Forward P/E 9.8x
EPS (TTM) $5.44
PEG Ratio N/A
Dividend Yield 0.89%
Revenue (TTM) $3.8B
Profit Margin 12.8%
52-WEEK RANGE
52-Week Low $31.19
52-Week High $79.11
Current Price $70.72
Bear Target $36.0
Bull Target $101.0
● Now $70.72 ● Target $82.88
TRADING DATA
Avg Volume 735K
YTD Return +88.1%
Analyst Count 8
Consensus Buy
Upside to Target +17.2%
Last Updated 2026-11-14

ANALYST SUMMARY

Marex Group Limited (MRX) is currently trading at $70.72 with a Wall Street consensus price target of $82.88, implying potential upside of 17.2% over the next 12 months. 8 analysts currently cover MRX, with a consensus rating of Buy - 88% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $101.0, while the most cautious has a target of $36.0.

MRX operates in the Financial Services sector with a market capitalisation of $5B. The stock is up 88.1% year-to-date and is currently trading near the upper end of its 52-week range of $31.19 – $79.11.

SIMILAR STOCKS

Other Financial Services stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-11-06 Building track record
William Blair ● Initiated
Outperform 2026-10-14 44% win rate (9 calls)
Barclays - Reiterated
Overweight → Overweight 2026-10-07 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-10-02 14% win rate (7 calls)
UBS - Reiterated
Buy → Buy 2026-08-13 33% win rate (6 calls)
Barclays - Reiterated
Overweight → Overweight 2026-08-13 Building track record
Keefe, Bruyette & Woods - Reiterated
Outperform → Outperform 2026-08-13 Building track record
Jefferies - Reiterated
Buy → Buy 2026-07-20 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
17/30
Consensus clarity
12/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →